Brief: Aura Biosciences FY Net Income USD -76.408 Million
27/03/2024 11:00
Mar 27 (Reuters) - Aura Biosciences FY operating income USD -84.991 million. * FY operating expenses USD 84.991 million
Recent news on Aura Biosciences
See all newsBrief: Aura Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Aura Biosciences - May Offer Securities Up To $500 Million Aggregate
Brief: Aura Biosciences Reports Second Quarter 2026 Financial Results And Recent Business Highlights
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Aura Biosciences Q1 net loss widens on higher R&D costs